- Home
- MX vs MIST Comparison
MX vs MIST Comparison
Compare MX & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MX | MIST |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | South Korea | Canada |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 146.9M |
| IPO Year | 2007 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MX | MIST |
|---|---|---|
| Price | $3.49 | $0.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $5.86 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 11-02-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.06 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $178,860,000.00 | N/A |
| Revenue This Year | $5.39 | $147.62 |
| Revenue Next Year | $6.37 | $476.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $0.75 |
| 52 Week High | $9.86 | $3.06 |
Technical Indicators
Market Signals| Indicator | MX | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 54.56 | 31.01 |
| Support Level | $2.65 | $0.75 |
| Resistance Level | $3.96 | $1.42 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 47.36 | 13.17 |
Price Performance
Historical ComparisonAbout MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The Company operates within a single operating segment, Power Solutions business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.